Radiation 'Re-Priming' could supercharge CAR-T therapy in stubborn lymphoma
NCT ID NCT04601831
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether adding focused radiation to leftover cancer spots can improve outcomes for people with non-Hodgkin lymphoma whose tumors didn't fully respond to CAR-T cell therapy. Fourteen adults received radiation to those remaining areas. The goal was to see if this combination is safe and helps more patients achieve a complete response by day 90 after CAR-T.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- focal radiation therapy
- What this could lead to
- If successful, this approach could help more patients achieve complete remission after CAR-T therapy, potentially improving long-term outcomes for hard-to-treat lymphoma.
- What could go wrong
- This is a small, early-phase trial with only 14 participants, so results may not apply broadly. Radiation carries risks like skin burns, pneumonitis, or other side effects, and the added benefit over CAR-T alone is uncertain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIFFUSE LARGE B-CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UT Southwestern Medical Center
Dallas, Texas, 75390, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can immune cells plus a checkpoint drug outsmart lymphoma?
- Can an immune booster outsmart brain lymphoma?
- A shot at safer CAR t: early brain protection for lymphoma patients?
- Can a gentler chemo prep make stem cell transplants safer for blood cancer patients?
- A simple blood test may reveal hidden infertility risk in young cancer survivors
- Can donor immune cells be engineered to fight blood cancer?